Hyperammonemia and encephalopathy in patients with multiple myeloma [3]

American Journal of Hematology

Volumn 82, Issue 5, 2007, Pages 414-415

  Talamo, Giampaolo ^a   Cavallo, Federica ^a   Zangari, Maurizio ^a   Barlogie, Bart ^a   Lee, Choon Kee ^a   Pineda Roman, Mauricio ^a   Kiwan, Elias ^a   Krishna, Somashekar ^a   Tricot, Guido ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA;

AMMONIA BLOOD LEVEL; BRAIN DISEASE; DISEASE ASSOCIATION; HUMAN; HYPERAMMONEMIA; LETTER; LIVER DYSFUNCTION; MENTAL HEALTH; MULTIPLE MYELOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

AMMONIA; BRAIN; BRAIN DISEASES, METABOLIC; HUMANS; HYPERAMMONEMIA; MULTIPLE MYELOMA; RETROSPECTIVE STUDIES;

EID: 34247548782     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20808     Document Type: Letter

References (5)

1. Malsuzaki H, Hata H, Sonoki T, et al. Serum amino acid disturbance in multiple myeloma with hyperammonemia. Int J Hematol 1995;61:131-137.
2. Matsuzaki H, Matsuno F, Yoshida M, Hata H, Okazaki K, Takatsuki K. Human myeloma cell line (KHM-4) established from a patient with multiple myeloma associated with hyperammonemia. Intern Med 1992;31:339-343.
3. Otsuki T, Yamada O, Sakaguchi H, et al. In vitro excess ammonia production in human myeloma cell lines. Leukemia 1998;12:1149-1158.
4. Fassas AB, Muwalla F, Berryman T, et al. Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations. Br J Haematol 2002;117:103-108.
5. Mathias RS, Kostiner D, Packman S. Hyperammonemia in urea cycle disorders: Role of the nephrologist. Am J Kidney Dis 2001;37:1069-1080.